Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | PLG | P00747 | 1/20 | 0.32 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.32 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.32 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.32 |
| ▸ | KCNJ8 | Q15842 | 1/20 | 0.32 |
| ▸ | GABRP | O00591 | 2/20 | 0.31 |
| ▸ | GABRD | O14764 | 2/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.31 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.31 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL179494 | 0.63 | GABRA1 (0.43) | DAOLMNAMAPTPLGGABRP | |
| SCHEMBL179486 | 0.62 | DAO (0.60) | DAOALDH1A1LMNAPOLBMAPT | |
| SCHEMBL6671097 | 0.60 | — | — | |
| SCHEMBL571512 | 0.59 | DAO (0.40) | DAOALDH1A1LMNAPOLBMAPT | |
| SCHEMBL15474293 | 0.59 | DAO (0.35) | DAOALDH1A1KDM4EGLAGAA | |
| SCHEMBL7764663 | 0.59 | CA1 (0.56) | DAOALDH1A1LMNAKDM4EGLA | |
| SCHEMBL18701493 | 0.57 | CA1 (0.43) | DAOALDH1A1LMNAPOLBMAPT | |
| SCHEMBL10256269 | 0.57 | GABRA1 (0.41) | DAOALDH1A1LMNAPOLBMAPT | |
| SCHEMBL13268569 | 0.57 | GPR84 (0.47) | DAOGABRA1GABRB2 | |
| SCHEMBL21305806 | 0.56 | ALDH1A1 (0.50) | DAOALDH1A1LMNAPOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10442828-B2 | Kinase inhibitors | TOPIVERT PHARMA LIMITED (GB) | 2019-10-15 | — | — | US | disclosed |
| US-9839639-B2 | Neprilysin inhibitors | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2017-12-12 | — | — | US | disclosed |
| US-20170291917-A1 | KINASE INHIBITORS | OXULAR ACQUISITIONS LIMITED (GB) | 2017-10-12 | — | — | US | disclosed |
| US-20170291917-A1 | KINASE INHIBITORS | OXULAR ACQUISITIONS LIMITED (GB) | 2017-10-12 | — | — | US | disclosed |
| US-20170189399-A1 | NEPRILYSIN INHIBITORS | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2017-07-06 | — | — | US | disclosed |
| US-20170144971-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | AMGEN INC. (US) | 2017-05-25 | — | — | US | disclosed |
| US-20100105814-A1 | ULTRAVIOLET ABSORBENT AND POLYMER MATERIAL CONTAINING THE SAME | FUJIFILM CORPORATION (JP) | 2010-04-29 | — | — | US | disclosed |
| EP-0824720-B1 | ACID BLEACHABLE DYE CONTAINING LITHOGRAPHIC PRINTING PLATE COMPOSITION | MINNESOTA MINING & MFG (US) | 1999-09-22 | — | — | EP | disclosed |
| EP-0824720-A1 | ACID BLEACHABLE DYE CONTAINING LITHOGRAPHIC PRINTING PLATE COMPOSITION | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-02-25 | — | — | EP | disclosed |
| US-5665522-A | Visible image dyes for positive-acting no-process printing plates | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-09-09 | — | — | US | disclosed |
| WO-1996035143-A1 | ACID BLEACHABLE DYE CONTAINING LITHOGRAPHIC PRINTING PLATE COMPOSITION | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-11-07 | — | — | WO | disclosed |
| EP-0412379-B1 | Silver halide colour photographic light-sensitive materials | FUJI PHOTO FILM CO LTD (JP) | 1996-05-15 | — | — | EP | disclosed |
| EP-0412379-A1 | Silver halide colour photographic light-sensitive materials | FUJI PHOTO FILM CO., LTD. (JP) | 1991-02-13 | — | — | EP | disclosed |
| EP-0125253-A1 | A PROCESS FOR THE PREPARATION OF 3-HYDROXY-ISOXAZOLOLE | A/S CHEMINOVA (DK) | 1984-11-21 | — | — | EP | disclosed |
| WO-1984001774-A1 | A PROCESS FOR THE PREPARATION OF 3-HYDROXY-ISOXAZOLOLE | CHEMINOVA AS (DK) | 1984-05-10 | — | — | WO | disclosed |
| EP-0010262-B1 | PROCESS FOR PREPARING 3-AMINO-5-T-BUTYLISOXAZOLE | SHIONOGI & CO., LTD. (JP) | 1983-01-26 | — | — | EP | disclosed |
| US-4256899-A | REACTING PIVALOYLACETONITRILE WITH HYDROXYLAMINE, TREATING WITH A MINERAL ACID | SHIONOGI & CO., LTD. (JP) | 1981-03-17 | — | — | US | disclosed |
| EP-0010262-A1 | Process for preparing 3-amino-5-t-butylisoxazole | SHIONOGI & CO., LTD. (JP) | 1980-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105814-A1 | ULTRAVIOLET ABSORBENT AND POLYMER MATERIAL CONTAINING THE SAME | UGT1A6, MCM6, MSH6 | DAO 3716/4885ALDH1A1 1776/4885LMNA 3592/4885 |
| US-10442828-B2 | Kinase inhibitors | SYK, LTK, LTB4R | DAO 3015/4885ALDH1A1 4550/4885LMNA 4232/4885 |
| US-20170291917-A1 | KINASE INHIBITORS | SYK, LYN, BTK | DAO 3296/4885ALDH1A1 4786/4885LMNA 4562/4885 |
| US-20170144971-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | MDM2, TP53, CDKN1A | DAO 4144/4885ALDH1A1 332/4885LMNA 2556/4885 |
| US-20170189399-A1 | NEPRILYSIN INHIBITORS | MME, REN, ACE | DAO 2586/4885ALDH1A1 2655/4885LMNA 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.